Table 3.
Diagnostic accuracy of a first and a repeat EUS-guided fine needle biopsy for the diagnosis of solid pancreatic lesions.
| Entire Cohort (n = 102) | Repeat EUS FNB (n = 34) | Single EUS FNB (n = 68) | p | |
|---|---|---|---|---|
| Final diagnosis on pathology-n (%) | 90 (88) | 25 (74) | 65 (96) | 0.05 |
| Pancreatic adenocarcinoma-n (%) | 71 (70) | 20 (60) | 51 (75) | 0.094 |
| Neuroendocrine tumor-n (%) | 14 (14) | 3 (9) | 11 (16) | 0.476 |
| Autoimmune pancreatitis-n (%) | 3 (3) | 3 (9) | 1 (2) | 0.534 |
| Pancreatic metastasis-n (%) | 2 (2) | 1 (3) | 1 (2) | 1.000 |
| Chronic pancreatitis-n (%) | 4 (4) | 5 (15) | 1 (2) | 0.207 |
| Other–n (%) | 7 (7) | 2 (6) * | 3 (5) ** | 0.332 |
*: degenerated IPMN, and normal pancreas. **: degenerated IPMN and two normal pancreas. EUS: Endoscopic Ultrasound. FNB: Fine Needle Biopsy. IPMN: Intraductal Papillary Mucinous Neoplasm.